Chapter 1057 Deduction and Auction

The so-called dead camel is bigger than a horse. Moreover, Pfizer's stock price was only affected a little, but the actual assets and liquidity were not affected much.

Pfizer has not been greatly affected by scandals in the development of certain drugs.

Being able to become the No. 1 pharmaceutical company in Sam Country, or even the No. 1 pharmaceutical company in the world, will definitely not be a simple company.

Being able to stand for Sam Kingdom for nearly 170 years is almost on a par with the short history of Sam Kingdom. How could such a company simply collapse.

"Minimum discounted price? What is the minimum discounted price?"

Zhang Guoqing never thought that he could win so many drugs at the cost price. The cost price is just a cover.

"According to our company's lowest price to other suppliers, it will drop by 10%." Mark quickly gave his new quotation.

"The lowest price is 10% lower? How do I know what the lowest price your company offers to other suppliers? This is not enough? Otherwise, you should pay cash."

Zhang Guoqing shook his head. In terms of quotations, it is too easy to falsify. If Pfizer Pharma randomly makes a quotation, it can be said to be the lowest quotation for the supplier. At that time, will he accept it or not?

In fact, it can be seen that Pfizer really wants to cheat.

Feiyun collected relevant information on most companies last time, and Pfizer's various drug prices to suppliers are also included.

However, Zhang Guoqing did not know about this matter, only Liu Mingyu knew it.

Hearing that Zhang Guoqing had rejected his request, Mark quickly said: "President Zhang, don't worry, the price used for deduction is definitely the lowest discount on the market. If Mr. Zhang doesn't believe it, we will give the cost price. It's useless, because again there is no standard price."

What Mark said was the truth. After thinking about it carefully, Zhang Guoqing also felt that something was wrong, and immediately responded: "Well, 400 million US dollars will be paid in cash, and the remaining 100 million US dollars will be deducted with drugs, and a 10% drop in the quotation will definitely not work. Yes, it will drop by 30%. If it works, I will ask my secretary to send you the name and quantity of the medicine you need, so there should be no problem, right? If there is still a problem, then I am helpless."

Mark laughed loudly: "Mr. Zhang, there is no problem."

Zhang Guoqing's knife was cut hard enough, and the lowest price dropped by 30%.

But for Pfizer, a 30% drop is still lucrative.

The drug cost of most drugs is not very high, mainly because the research and development cost is high. Amortizing the research and development cost to each drug will naturally increase the price of the drug.

But for Pfizer, except for those newly developed drugs, the research and development costs of most of the drugs have already been recovered.

Therefore, even a 30% drop is not so unacceptable for Pfizer.

Sometimes, even if they lose money, they have to win this cooperation quota, which is related to Pfizer's later development strategy.

"Pleasant to work with."

Zhang Guoqing stretched out his right hand towards Mark.

"Pleasant to work with."

Mark hurriedly stood up, clasping his hands tightly together.

Mark expressed his satisfaction that he was able to complete the task successfully this time, and his job was finally saved.

It seems that Pfizer has also spent 500 million US dollars, but unlike Ito, Ito won the exclusive agency of Neon, while Pfizer won only a published list of cooperation.

Sam Kingdom, as the largest country on this planet, Xingchen Pharmaceutical could not just release the exclusive agency rights like this, it is not a question of how much money.

It is useless to scale up to tens of billions of dollars.

It's okay to find a large company to cooperate with, and Pfizer is a good choice.

And the reason why Pfizer spends huge sums of money to obtain a list of cooperation in Caucasian clinical trials of generic cancer drugs is not precisely this idea.

Everything needs to wait for the completion of clinical trials before continuing to negotiate.

Mark is also very aware of this situation, so he consciously did not continue to talk about the issue of exclusive agency.

It's just that he didn't know that his old rival, Ito Pharmaceutical, had secretly won the exclusive agency of the generic cancer drug in Neon Country. If he knew, he wouldn't be so calm.

After talking with Mark, it was almost noon.

Zhang Guoqing directly asked representatives from other countries to gather in the No. 1 conference room, and no longer negotiated with them slowly.

Representatives from other companies gathered in the conference room No. 1 after receiving the notice.

The top pharmaceutical companies on the planet are gathered here. It is no exaggeration to say that the products produced by these companies almost include more than 80% of the drugs on the market.

Only Xingchen Pharmaceutical has such an appeal to bring together the world's famous pharmaceutical companies.

Although these pharmaceutical companies are not as famous as Pfizer and Ito, they are also well-known.

After everyone received the notice, it was still a bit baffling, didn't they make an appointment according to the appointment time?

Why did we start a meeting all of a sudden?

When they saw that the conference room was all peers, they suddenly thought of something.

Before they could ask each other about the situation, the door of the conference room opened, and Zhang Guoqing walked straight to the rostrum.

Zhang Guoqing looked at the people in the audience and laughed softly: "As for everyone's intentions, I already know. First of all, I am here to express my position on behalf of the company. Except for Huaxia, all agency rights can be represented."

It’s too troublesome to talk one by one, bringing people together and directly mentioning the requirements, companies that want agency rights must follow the rules of Xingchen Pharmaceutical.

Now it is a seller's market, either accept the conditions of Xingchen Pharmaceutical, or leave automatically.

He does not worry that no one buys the agency rights. If no one buys it, it doesn't matter. At most, the company is a little more troublesome, and it is enough to set up an international department.

As for the clinical trials of each country, Xingchen Pharma does not have to do it by itself. Those who want to win the agency will do it themselves.

As soon as Zhang Guoqing's words fell, there was a burst of heated discussions from the audience.

These companies sent people here because they hoped to get the agency rights of general cancer drugs. Now that Xingchen Pharma has agreed to open up the international agency rights, the minds of all representatives became active for a while.

Some prominent people have returned the news to headquarters.

Although Zhang Guoqing has not said how to obtain the agency rights of general cancer drugs, there is no doubt that it will definitely be a huge price.

They have to be prepared for the eventuality.